<DOC>
	<DOCNO>NCT00520559</DOCNO>
	<brief_summary>The purpose study provide accurate prognostic data link cardiac complication myocardial T2* value ( A measure iron level heart use MRI ) patient predisposed heart iron overload .</brief_summary>
	<brief_title>T2* Transfusion Dependant Anemia , MI , LVF , Normal Patients</brief_title>
	<detailed_description>Key Definitions Myocardial siderosis - Iron deposition occur heart , usually relation recurrent blood transfusion red cell breakdown . Thalassaemia - A hereditary form anaemia lead recurrent blood transfusion iron overload . Cardiomyopathy - Disease heart lead heart failure . In case cardiac siderosis entirely reversible . Chelation - Drug use remove iron heart T2* CMR - Cardiac Magnetic Resonance Imaging . A specialised scan us large magnet image heart . As iron magnetic property use scan determine amount iron within heart . T2* value relate level iron load heart . A T2* le 10 relates severe heart iron loading , T2* 10-20 relates mild/moderate heart iron load T2* great 20 relates significant iron load heart . Heart failure - Disease myocardium ( heart muscle ) weaken pump blood efficiently . Fluid accumulate lung , hand , ankle , part body . The mortality heart failure high . Heterozygotes - An individual one normal one abnormal thalassaemia gene . They carriers thalassaemia gene milder clinical manifestation . Homozygotes - An individual inherited abnormal thalassaemia gene produce severe form disease . Question Response Although rare disease UK , thalassaemia common genetic disorder worldwide , approximately 94 million heterozygote beta thalassaemia 60,000 homozygote born year . In United Kingdom , despite relatively easy access healthcare , approximately 50 % patient thalassaemia major die reach age thirty five . Of death , 60 % result heart failure . The cardiomyopathy reversible chelation commence early diagnosis often delay due late onset symptom measurable LV dysfunction . This study provide strong evidence myocardial T2* &lt; 10ms represent high risk develop cardiac complication . Derived risk ratio provide sound guidance life save chelation require . A database produce contain clinical data T2* value 665 thalassaemia patient 1998-2006 . A diagnosis heart failure make patient ejection fraction le 55 % ( measure CMR echocardiography ) symptom per NHYA classification within 1 year CMR scan . A diagnosis arrhythmia make patient document ECG evidence within 1 year CMR scan . This information gather retrospectively access outpatient clinic letter , hospital note , CMR/ echo report clinical detail record proforma time CMR scan . Some clinical data would obtain hospital . Patient scan use date 1999-2005 . As data respect year immediately post scan data require patient post 2006 . Logistic regression use determine whether T2* predictive cardiac complication 12 month patient 's CMR scan . Since patient 1 scan , mixed model logistic regression use take account within-patient correlation may occur . The data analyse Dr Michael Roughton ( Medical Statistician , Royal Brompton Hospital ) The result disseminate peer review journal</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<criteria>Thalassaemia Major Patient must cardiac MRI scan 1999 2006 Other structural heart disease valvular abnormality , MI , congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>